Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial.

Scirica, Benjamin M; Bhatt, Deepak L; Braunwald, Eugene; Raz, Itamar; Cavender, Matthew A; Im, KyungAh; Mosenzon, Ofri; Udell, Jacob A; Hirshberg, Boaz; Pollack, Pia S; Steg, Ph Gabriel; Jarolim, Petr; Morrow, David A

Scirica, Benjamin M; Bhatt, Deepak L; Braunwald, Eugene; Raz, Itamar; Cavender, Matthew A; Im, KyungAh; Mosenzon, Ofri; Udell, Jacob A; Hirshberg, Boaz; Pollack, Pia S; Steg, Ph Gabriel; Jarolim, Petr; Morrow, David A.

Afiliación

Scirica BM; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Bhatt DL; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Braunwald E; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Raz I; Diabetes Unit, Division of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel.
Cavender MA; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Im K; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Mosenzon O; Diabetes Unit, Division of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel.
Udell JA; Women's College Research Institute and Cardiovascular Division, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada4Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Hirshberg B; AstraZeneca Research and Development, Gaithersburg, Maryland.
Pollack PS; AstraZeneca Research and Development, Gaithersburg, Maryland.
Steg PG; National Heart and Lung Institute, Imperial College, Institute of Cardiovascular Medicine and Science, Royal Brompton Hospital, London, England7INSERM U-1148, Département Hospitalo-Universitaire FIRE (Fibrosis-Inflammation-Remodelling), Université Paris-Diderot, Paris, France8Hôpital Bichat, Assista
Jarolim P; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Morrow DA; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

JAMA Cardiol ; 1(9): 989-998, 2016 Dec 01.

Article en En | MEDLINE | ID: mdl-27681000

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JAMA Cardiol Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google